HCPCS Level II drug code
J9264 — Injection, paclitaxel protein-bound particles, 1 mg
In short
J9264 is the HCPCS Level II code for injection, paclitaxel protein-bound particles, 1 mg. CMS assigns NDCs for Abraxane, Paclitaxel Protein-Bound, Paclitaxel Protein-Bound (American Regent) and Paclitaxel Protein-Bound Particles to it. One billing unit is 1 mg. The Medicare Part B payment limit is $3.64 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, paclitaxel protein-bound particles, 1 mg
- Short descriptor
- Paclitaxel protein bound
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2007
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J9264
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 11 NDCs to J9264 for Abraxane, Paclitaxel Protein-Bound, Paclitaxel Protein-Bound (American Regent) and Paclitaxel Protein-Bound Particles. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Abraxane | 68817-0134-50 | Celgene Corporation | 1 | 100 |
| Paclitaxel Protein-Bound | 00517-4300-01 | American Regent, Inc. | 1 | 100 |
| Paclitaxel Protein-Bound | 24979-0710-51 | TWI Pharmaceuticals, Inc. | 1 | 100 |
| Paclitaxel Protein-Bound | 60505-6230-04 | Apotex Corp | 1 | 100 |
| Paclitaxel Protein-Bound | 68001-0651-37 | BluePoint Laboratories | 1 | 100 |
| Paclitaxel Protein-Bound | 69097-0398-78 | Cipla USA, Inc. | 1 | 100 |
| Paclitaxel Protein-Bound | 71288-0183-50 | Meitheal Pharmaceuticals Inc. | 1 | 100 |
| Paclitaxel Protein-Bound (American Regent) | 00480-3290-01 | Teva Pharmaceuticals USA, Inc. | 1 | 100 |
| Paclitaxel Protein-Bound Particles | 00781-3531-91 | Sandoz Inc. | 1 | 100 |
| Paclitaxel Protein-Bound Particles | 67457-0937-50 | Mylan Institutional LLC | 1 | 100 |
| Paclitaxel Protein-Bound Particles | 72603-0408-01 | Northstar RxLLC | 1 | 100 |
J9264: common questions
- Is J9264 a CPT code?
- No. J9264 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J9264?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 11 NDCs under J9264, for Abraxane, Paclitaxel Protein-Bound, Paclitaxel Protein-Bound (American Regent) and Paclitaxel Protein-Bound Particles. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J9264?
- $3.64 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J9264?
- One unit of J9264 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.